Status:
COMPLETED
Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia
Lead Sponsor:
Methodist Health System
Conditions:
Stenotrophomonas Maltophilia Infection
Eligibility:
All Genders
18+ years
Brief Summary
Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from th...
Detailed Description
Stenotrophomonas maltophilia is an aerobic, non-fermenting, Gram-negative bacillus recognized by the World Health Organization as one of the leading multi-drug resistant nosocomial pathogens worldwide...
Eligibility Criteria
Inclusion
- ≥18 years of age
- S. maltophilia isolated on respiratory or blood culture
Exclusion
- Those that do not meet the inclusion criteria outlined in Section 4.1.
Key Trial Info
Start Date :
July 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 14 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06112938
Start Date
July 21 2022
End Date
July 14 2025
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75201